VARICELLA-ZOSTER VIRUS
Clinical trials for VARICELLA-ZOSTER VIRUS explained in plain language.
Never miss a new study
Get alerted when new VARICELLA-ZOSTER VIRUS trials appear
Sign up with your email to follow new studies for VARICELLA-ZOSTER VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New mRNA shingles vaccine shows promise in Mid-Stage trial
⭐️ VACCINE ⭐️ OngoingThis study tests a new mRNA vaccine (ABO1108) to see if it can safely prevent shingles in adults aged 40 and older. About 300 healthy volunteers or those with stable health conditions will receive two shots, two months apart. Researchers will measure the body's immune response an…
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE2 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:59 UTC
-
New mRNA shingles vaccine moves to human testing
⭐️ VACCINE ⭐️ OngoingThis early-stage trial tests a new mRNA vaccine (ABO1108) to prevent shingles in 180 healthy adults aged 40 and older. Participants receive two shots about two months apart at different dose levels. The main goal is to check the vaccine's safety and how well the body responds to …
Matched conditions: VARICELLA-ZOSTER VIRUS
Phase: PHASE1 • Sponsor: Suzhou Abogen Biosciences Co., Ltd. • Aim: ⭐️ VACCINE ⭐️
Last updated May 26, 2026 11:09 UTC